Zealand Pharma A/S

Biotechnology • Healthcare • Søborg, Denmark • ZLDPF (PNK)

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States. The company has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. It also provides Zegalogue, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon for treating congenital hyperinsulinism. In addition, the company developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. Zealand Pharma A/S was incorporated in 1997 and is based in Søborg, Denmark.

Stock Performance (90 Days)

Data through Dec 23, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Zealand Pharma A/S (OTCMKTS:ZLDPF) Sees Strong Trading Volume - Should You Buy? - MarketBeat

MarketBeat • Jan 2

Zealand Pharma A/S (OTCMKTS:ZLDPF) Shares Gap Down - What's Next? - MarketBeat

MarketBeat • Dec 30

Zealand Pharma AS (ZLDPF) Q1 2025 Earnings Call Highlights: Strategic Collaborations and ... - Yahoo Finance

Yahoo Finance • May 9

Zealand inks deal with Chinese pharma to develop oral drugs for metabolic diseases - Seeking Alpha

Seeking Alpha • Dec 11

Roche shares pop 4% on $5.3 billion obesity drug deal with Zealand Pharma - CNBC

CNBC • Mar 12

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Zealand Pharma A/S/ADR had layoffs?

No layoff events have been recorded for Zealand Pharma A/S/ADR in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Zealand Pharma A/S/ADR have?

Zealand Pharma A/S/ADR has approximately 440 employees.

What industry is Zealand Pharma A/S/ADR in?

Zealand Pharma A/S/ADR operates in the Biotechnology industry, within the Healthcare sector.

Is Zealand Pharma A/S/ADR a publicly traded company?

Yes, Zealand Pharma A/S/ADR is publicly traded under the ticker symbol ZLDPF on the PNK. The company has a market capitalization of approximately $5.47 billion.

Where is Zealand Pharma A/S/ADR headquartered?

Zealand Pharma A/S/ADR is headquartered in Søborg, Denmark.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.